Imam Reza Shrine's Affiliated Company Boosts Iran's Pharmaceutical Industry
TEHRAN (Tasnim) – Samen Company, affiliated with the Endowment Beneficiary Foundation of Imam Reza shrine, stands as a stalwart in Iran's pharmaceutical sector, contributing to the nation's self-sufficiency in medication since the 1979 Islamic Revolution.
Established in 1992 in Mashhad, northeast Iran, Samen Pharmaceutical Company specializes in producing small, medium, and large volume solutions for injection and irrigation, addressing critical healthcare needs.
With a repertoire of over 90 products, including 50 first-time productions in Iran, Samen Company covers a wide range of pharmaceuticals, from nutritional solutions to dialysis solutions and anticoagulants, marking strategic advancements in the industry.
Among its notable contributions are Large Volume Parenteral (LVP) solutions and antibiotics, vital components of Iran's healthcare infrastructure, ensuring accessibility and affordability for patients nationwide.
Furthermore, Samen has prioritized addressing incurable diseases, particularly focusing on kidney failure patients. Since 1995, the company has monopolized the production of Peritoneal Dialysis solutions, providing essential care for those with acute kidney conditions.
In its commitment to societal well-being, Samen Company also caters to specialized healthcare needs, distinguishing itself from competitors. Notably, it produces Sodium Chloride-Irrigation, crucial for Cystic Fibrosis patients, and essential solutions like Cardioplegic Solution and Plasmalyte Solution for open-heart surgery, enhancing access to critical medical interventions.
